TrialAnnals of oncology : official journal of the European Society for Medical Oncology2025

Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial.

T K Choueiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.